Candelanza, Mylyn B.

HRN: 01-98-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/28/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/28/2024
08/04/2024
IV
1.5gms
Q6
CAP MR
Waiting Final Action 
07/28/2024
AZITHROMYCIN 500MG TABLET (TAB)
07/28/2024
08/01/2024
PO
500mg
OD
CAP MR
Waiting Final Action 
07/28/2024
CEFTRIAXONE 1G (VIAL)
07/28/2024
08/03/2024
IV
2gm
OD
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: